Neogen Corporation (NEOG) Key Metrics

NASDAQ: NEOGValuation, returns, debt and efficiency ratios over 10 years.

NEOG valuation today

Trailing 12 months · as of October 18, 2026
Market cap
$2.58B
Enterprise value
$3.57B
P/E (TTM)
—
10-yr median 60.9
Forward P/E
16.0
PEG ratio
0.66
Price / sales
2.9
10-yr median 6.1
Price / book
1.4
10-yr median 3.9
EV / EBITDA
20.9
10-yr median 29.7
Dividend yield
—
Beta
1.79

NEOG key metrics, FY2017–FY2026

Fiscal year ended May 31, 2026 · U.S. dollars

NEOG valuation Price multiples at each fiscal year-end price.

Price / sales+57.8%
2.2
FY2026 · hover or tap a bar for each year
FY2017: 6.7 (+15.4%)FY2018: 9.8 (+46.2%)FY2019: 7.1 (−27.4%)FY2020: 9.0 (+26.2%)FY2021: 10.6 (+17.2%)FY2022: 5.4 (−48.6%)FY2023: 4.0 (−25.9%)FY2024: 3.1 (−23.3%)FY2025: 1.4 (−53.9%)FY2026: 2.2 (+57.8%)
FY2017FY2026
Price / book+51.9%
0.9
FY2026 · hover or tap a bar for each year
FY2017: 5.1 (+11.3%)FY2018: 7.1 (+37.0%)FY2019: 4.6 (−34.3%)FY2020: 5.2 (+12.1%)FY2021: 5.9 (+13.3%)FY2022: 3.2 (−45.3%)FY2023: 1.1 (−67.3%)FY2024: 0.9 (−14.1%)FY2025: 0.6 (−32.2%)FY2026: 0.9 (+51.9%)
FY2017FY2026
EV / EBITDA
15.5
FY2026 · hover or tap a bar for each year
FY2017: 28.7 (+12.1%)FY2018: 42.9 (+49.4%)FY2019: 29.7 (−30.8%)FY2020: 37.7 (+27.2%)FY2021: 47.4 (+25.6%)FY2022: 29.4 (−38.0%)FY2023: 31.4 (+6.9%)FY2024: 19.6 (−37.6%)FY2026: 15.5
FY2017FY2026
Price / free cash flow
61.2
FY2026 · hover or tap a bar for each year
FY2017: 53.2 (−40.0%)FY2018: 82.0 (+54.2%)FY2019: 60.1 (−26.7%)FY2020: 60.9 (+1.4%)FY2021: 90.9 (+49.3%)FY2022: 65.5 (−27.9%)FY2026: 61.2
FY2017FY2026
Free cash flow yield+5.3 pts
1.6%
FY2026 · hover or tap a bar for each year
FY2017: 1.9% (+0.8 pts)FY2018: 1.2% (−0.7 pts)FY2019: 1.7% (+0.4 pts)FY2020: 1.6% (0.0 pts)FY2021: 1.1% (−0.5 pts)FY2022: 1.5% (+0.4 pts)FY2023: −0.7% (−2.3 pts)FY2024: −2.7% (−1.9 pts)FY2025: −3.6% (−1.0 pts)FY2026: 1.6% (+5.3 pts)
FY2017FY2026

NEOG valuation history

Fiscal year-endToday10-year median

NEOG returns on capital

ROEROICROA

Net income (ROE, ROA) or after-tax operating income (ROIC) divided by the average of the opening and closing balance.

NEOG debt vs cash

Total debtCash & short-term investments

Debt includes short- and long-term borrowings and, where reported, lease liabilities.

NEOG cash returned to shareholders

DividendsBuybacksFree cash flow

NEOG price vs earnings per share

Share price at year-endEPS (right axis)

NEOG key metrics

FY2017–FY2026
Neogen Corporation key metrics by fiscal year
FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Valuation
Market capitalization$1.95B$1.27B$2.85B$3.30B$2.86B$4.94B$3.76B$2.95B$3.95B$2.43B
Enterprise value$2.56B$2.05B$3.58B$3.96B$2.48B$4.56B$3.42B$2.69B$3.74B$2.29B
P/E ratio————59.281.263.349.162.655.5
Price / sales2.21.43.14.05.410.69.07.19.86.7
Price / book0.90.60.91.13.25.95.24.67.15.1
Price / free cash flow61.2———65.590.960.960.182.053.2
Price / operating cash flow23.421.880.780.542.061.043.846.357.240.3
EV / sales2.92.33.94.84.79.78.26.59.36.3
EV / EBITDA15.5—19.631.429.447.437.729.742.928.7
EV / free cash flow80.2———56.883.955.454.677.650.0
Earnings yield−0.4%−85.9%−0.3%−0.7%1.7%1.2%1.6%2.0%1.6%1.8%
Free cash flow yield1.6%−3.6%−2.7%−0.7%1.5%1.1%1.6%1.7%1.2%1.9%
Dividend yield————————0.0%0.0%
Shareholder yield (dividends + buybacks)———0.0%0.0%0.0%0.0%0.1%0.0%0.0%
Share price at fiscal year-end$8.97$5.86$13.15$17.49$26.46$46.16$35.61$28.18$37.85$23.74
Per share
Revenue per share$4.00$4.12$4.27$4.35$4.88$4.37$3.96$3.95$3.85$3.53
Earnings per share−$0.04−$5.03−$0.04−$0.12$0.45$0.57$0.56$0.57$0.60$0.43
Operating cash flow per share$0.38$0.27$0.16$0.22$0.63$0.76$0.81$0.61$0.66$0.59
Free cash flow per share$0.15−$0.21−$0.35−$0.13$0.40$0.51$0.58$0.47$0.46$0.45
Cash per share$0.85$0.59$0.79$1.30$3.53$3.56$3.25$2.55$2.02$1.40
Book value per share$9.62$9.55$14.52$16.59$8.21$7.85$6.86$6.08$5.37$4.61
Tangible book value per share−$1.25−$1.86−$2.32−$3.22$5.90$5.76$5.19$4.45$3.75$2.91
Dividends per share————————$0.00$0.00
Capex per share$0.24$0.48$0.51$0.35$0.23$0.25$0.23$0.14$0.20$0.14
Debt per share$3.65$4.21$4.19$4.75$0.01$0.01$0.01—$0.00$0.00
Shares outstanding217.5M216.9M216.5M188.9M108.0M107.1M105.7M104.8M104.4M102.3M
Change in shares outstanding+0.3%+0.2%+14.6%+74.9%+0.8%+1.3%+0.8%+0.5%+2.0%+1.3%
Returns & profitability
Return on equity (ROE)−0.4%−41.9%−0.3%−1.1%5.6%7.8%8.7%10.0%12.2%10.0%
Return on invested capital (ROIC)−0.6%0.2%1.6%1.4%9.7%14.2%14.8%15.6%17.8%13.7%
Return on assets (ROA)−0.2%−27.3%−0.2%−0.8%5.1%7.1%8.0%9.2%11.0%8.9%
Return on tangible assets−0.8%−112.8%−1.0%−2.8%6.5%8.7%9.6%11.5%14.1%12.3%
Free cash flow margin3.7%−5.2%−8.2%−3.0%8.3%11.6%14.8%11.9%12.0%12.6%
Income quality (OCF / net income)————1.411.331.441.061.091.38
Financial health
Total debt$793.7M$912.6M$906.2M$897.5M$1.4M$1.3M$1.1M—$0$0
Cash & short-term investments$185.5M$129.0M$170.9M$245.6M$381.1M$381.1M$343.7M$267.5M$210.8M$143.6M
Net debt$608.2M$783.6M$735.3M$652.0M−$379.6M−$379.8M−$342.6M−$267.5M−$210.8M−$143.6M
Debt / equity0.380.440.290.290.000.000.00—0.000.00
Debt / assets0.240.260.200.200.000.000.00—0.000.00
Net debt / EBITDA3.69—4.035.18−4.50−3.94−3.78−2.95−2.42−1.80
Current ratio3.823.323.824.038.0511.0311.0811.759.718.14
Quick ratio2.912.222.593.116.489.169.129.507.756.11
Interest coverage-0.40.11.10.7814.1950.92.93.0——
Working capital$446.4M$402.9M$434.9M$440.5M$549.0M$537.9M$488.9M$411.3M$337.1M$257.0M
Invested capital$2.70B$2.85B$3.88B$3.79B$507.8M$460.6M$382.6M$370.4M$349.4M$328.1M
Tangible asset value−$272.3M−$404.1M−$503.1M−$608.4M$637.2M$616.6M$548.3M$466.7M$391.0M$298.1M
Net current asset value−$648.5M−$795.6M−$815.5M−$834.3M$521.2M$511.6M$465.4M$391.7M$318.0M$236.3M
Graham number————$9.09$10.02$9.32$8.86$8.55$6.66
Graham net-net per share−$4.07−$4.76−$4.66−$5.26$3.81$3.93$3.62$3.00$2.40$1.71
Capital allocation
Dividends paid————————$0$0
Share buybacks (net)———$0$0$0$0$3.1M$0$0
Dividend payout ratio————————0.0%0.0%
Dividends + buybacks / free cash flow————0.0%0.0%0.0%6.4%0.0%0.0%
Capex / revenue5.9%11.7%12.1%8.0%4.6%5.7%5.8%3.5%5.2%4.0%
Capex / operating cash flow61.7%179.6%316.0%160.3%35.9%32.9%28.0%23.0%30.3%24.2%
Capex / depreciation0.440.830.920.731.011.271.310.831.230.99
Stock-based compensation / revenue1.5%1.9%1.5%1.2%1.4%1.4%1.5%1.3%1.2%1.5%
R&D / revenue2.1%2.4%2.4%3.2%3.2%3.5%3.5%3.1%2.7%2.9%
SG&A / revenue47.3%24.4%21.6%41.6%31.7%26.6%27.3%26.8%27.1%26.7%
Efficiency
Days sales outstanding62.966.664.456.166.368.873.071.267.068.8
Days of inventory on hand132.4146.6127.7112.2143.2141.0148.9133.0128.4132.3
Days payables outstanding62.762.763.248.837.635.736.832.731.830.8
Cash conversion cycle (days)132.7150.4129.0119.6171.9174.1185.1171.6163.5170.3
Receivables turnover5.805.485.676.505.515.315.005.125.455.31
Payables turnover5.825.825.787.499.7110.239.9311.1711.4611.84
Inventory turnover2.762.492.863.252.552.592.452.742.842.76
Asset turnover0.260.220.200.300.550.550.560.630.700.74
Average receivables$150.1M$163.2M$163.1M$126.5M$95.7M$88.3M$83.6M$80.8M$73.8M$68.1M
Average payables$79.4M$81.3M$79.9M$55.6M$29.3M$24.8M$22.4M$19.9M$18.5M$16.0M
Average inventory$167.6M$190.1M$161.5M$128.1M$111.5M$97.9M$90.5M$81.0M$74.6M$68.8M
Intangibles / total assets70.7%71.9%80.2%82.2%25.2%24.3%22.2%24.6%27.4%32.9%

Computed from NEOG's annual financial statements (latest annual report filed July 30, 2026) and the closing share price on each fiscal year-end, adjusted for stock splits. Figures in U.S. dollars; data from EODHD. Averages use the opening and closing balance of each year.

NEOG valuation and financial ratios

Neogen earned a return on equity of −0.4% and a return on invested capital of −0.6% in fiscal 2026. It ended the year with $793.7 million of debt and $185.5 million in cash and short-term investments, net debt of $608.2 million. The share count rose 112.5% from 102.3M to 217.5M over 9 years.

See the NEOG income statement, the NEOG chart for price history, or the NEOG stock overview for the latest quote and news.

NEOG key metrics FAQ

What is Neogen's EV/EBITDA?

Neogen's enterprise value was 15.5 times EBITDA at the end of fiscal 2026 (enterprise value $2.6 billion, EBITDA $164.9 million); the current EV/EBITDA is 20.9.

What is Neogen's return on equity?

Neogen's return on equity (ROE) was −0.4% in fiscal 2026: net income of -$7.9 million on average shareholders' equity of $2.1 billion.

What is Neogen's ROIC?

Neogen's return on invested capital was −0.6% in fiscal 2026, using after-tax operating income divided by average debt plus equity minus cash.

How much debt does Neogen have?

Neogen had total debt of $793.7 million at the end of fiscal 2026, a debt-to-equity ratio of 0.38 and $608.2 million of net debt (3.69 times EBITDA).

What is Neogen's free cash flow yield?

Neogen generated $31.9 million of free cash flow in fiscal 2026, a free cash flow yield of 1.6% on its market value at year-end ($2.0 billion).

What is Neogen's current ratio?

Neogen's current ratio was 3.82 at the end of fiscal 2026: current assets were 3.82 times current liabilities.

Medical Devices key metrics